AI English summary of an SEC filing — figures as filed
STERIS STESTERIS said on April 10, 2024 that its wholly owned subsidiary, STERIS Corporation, entered into an Equity Purchase Agreement with HuFriedy Group Holding LLC, an affiliate of Peak Rock Capital, to sell the Dental segment for $787.5 million in cash, subject to customary adjustments.
Key points
AI summarySTERIS said on April 10, 2024 that its wholly owned subsidiary, STERIS Corporation, entered into an Equity Purchase Agreement with HuFriedy Group Holding LLC, an affiliate of Peak Rock Capital, to sell the Dental segment for $787.5 million in cash, subject to customary adjustments.
The company said the Dental business could receive up to an additional $12.5 million in contingent payments if it achieves certain revenue targets in fiscal 2025. It also said the buyer would be required to pay a termination fee of $35 million if the agreement is terminated under specified circumstances.
The company said completion of the transaction is subject to the satisfaction or waiver of certain conditions, including receipt of Hart-Scott-Rodino Act approvals. It said either party may terminate the agreement if the transaction has not closed by July 10, 2024, a date that may be extended to August 10. The company also said it expects the transaction to close in the first quarter of fiscal 2025.
The company said the Dental segment reported revenue of $407 million and segment operating income of $86 million for the trailing twelve-month period ended December 31, 2023. It said it plans to use the sale proceeds primarily to repay debt and expects the resulting reduction in interest expense to benefit diluted earnings by about $0.35 per share on a full-year run-rate basis.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Dental Segment Sale Agreement and Proceeds
STERIS said on April 10, 2024 that its wholly owned subsidiary, STERIS Corporation, entered into an Equity Purchase Agreement with HuFriedy Group Holding LLC, an affiliate of Peak Rock Capital, to sell the Dental segment for $787.5 million in cash, subject to customary adjustments.
Source · Based on the filing body and exhibits
Additional Consideration and Termination Fee
The company said the Dental business could receive up to an additional $12.5 million in contingent payments if it achieves certain revenue targets in fiscal 2025. It also said the buyer would be required to pay a termination fee of $35 million if the agreement is terminated under specified circumstances.
Source · Based on the filing body and exhibits
Closing Conditions and Expected Timing
The company said completion of the transaction is subject to the satisfaction or waiver of certain conditions, including receipt of Hart-Scott-Rodino Act approvals. It said either party may terminate the agreement if the transaction has not closed by July 10, 2024, a date that may be extended to August 10. The company also said it expects the transaction to close in the first quarter of fiscal 2025.
Source · Based on the filing body and exhibits
Dental Segment Results and Use of Proceeds
The company said the Dental segment reported revenue of $407 million and segment operating income of $86 million for the trailing twelve-month period ended December 31, 2023. It said it plans to use the sale proceeds primarily to repay debt and expects the resulting reduction in interest expense to benefit diluted earnings by about $0.35 per share on a full-year run-rate basis.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…